Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 19 studies | 58% ± 19% | |
| oligodendrocyte | 15 studies | 35% ± 14% | |
| oligodendrocyte precursor cell | 14 studies | 69% ± 19% | |
| glutamatergic neuron | 11 studies | 68% ± 25% | |
| GABAergic neuron | 10 studies | 59% ± 26% | |
| amacrine cell | 6 studies | 45% ± 25% | |
| neuron | 5 studies | 38% ± 16% | |
| interneuron | 5 studies | 64% ± 24% | |
| endothelial cell | 4 studies | 44% ± 19% | |
| granule cell | 4 studies | 66% ± 23% | |
| GABAergic amacrine cell | 3 studies | 36% ± 14% | |
| Mueller cell | 3 studies | 33% ± 6% | |
| glycinergic amacrine cell | 3 studies | 54% ± 3% | |
| retinal rod cell | 3 studies | 34% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 11628.96 | 2641 / 2642 | 100% | 101.95 | 702 / 705 |
| uterus | 62% | 844.63 | 106 / 170 | 25% | 1.82 | 113 / 459 |
| skin | 1% | 9.72 | 21 / 1809 | 79% | 11.34 | 372 / 472 |
| adrenal gland | 5% | 68.17 | 13 / 258 | 72% | 6.93 | 165 / 230 |
| kidney | 2% | 16.91 | 2 / 89 | 74% | 5.01 | 663 / 901 |
| intestine | 56% | 853.90 | 543 / 966 | 4% | 0.18 | 19 / 527 |
| breast | 10% | 86.03 | 44 / 459 | 18% | 1.30 | 204 / 1118 |
| lung | 0% | 4.08 | 2 / 578 | 17% | 0.99 | 198 / 1155 |
| ovary | 12% | 128.91 | 21 / 180 | 4% | 0.18 | 16 / 430 |
| esophagus | 3% | 26.47 | 40 / 1445 | 13% | 0.65 | 23 / 183 |
| bladder | 0% | 0 | 0 / 21 | 14% | 0.77 | 72 / 504 |
| liver | 4% | 43.91 | 10 / 226 | 9% | 0.53 | 38 / 406 |
| pancreas | 0% | 0 | 0 / 328 | 13% | 0.78 | 23 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.94 | 4 / 45 |
| stomach | 5% | 41.23 | 18 / 359 | 3% | 0.34 | 10 / 286 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.42 | 6 / 80 |
| prostate | 4% | 36.20 | 11 / 245 | 0% | 0 | 0 / 502 |
| thymus | 0% | 1.97 | 1 / 653 | 3% | 0.12 | 20 / 605 |
| adipose | 3% | 25.77 | 34 / 1204 | 0% | 0 | 0 / 0 |
| heart | 2% | 20.56 | 18 / 861 | 0% | 0 | 0 / 0 |
| muscle | 1% | 9.40 | 9 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 7.61 | 12 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 3.52 | 4 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0008021 | Cellular component | synaptic vesicle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030425 | Cellular component | dendrite |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | TRIM9 |
| Protein name | Tripartite motif containing 9 E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9) |
| Synonyms | RNF91 KIAA0282 |
| Description | FUNCTION: E3 ubiquitin-protein ligase which ubiquitinates itself in cooperation with an E2 enzyme UBE2D2/UBC4 and serves as a targeting signal for proteasomal degradation. May play a role in regulation of neuronal functions and may also participate in the formation or breakdown of abnormal inclusions in neurodegenerative disorders. May act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP25 for the SNARE complex formation. . |
| Accessions | ENST00000338969.9 [Q9C026-4] Q9C026 ENST00000298355.7 [Q9C026-1] ENST00000360392.4 [Q9C026-5] A0A804HIL7 ENST00000684578.1 |